Organ preservation treatment using TPF—a pilot study in patients with advanced primary and recurrent cancer of the oral cavity and the maxillary sinus

摘要

Purpose Induction chemotherapy with Taxotere, cisplatin, and 5-fluororacil (TPF) was mainly used in hypopharyngeal and laryngeal cancer patients for larynx preservation. This study aimed to assess feasibility and toxicity in oral cavity and maxillary sinus cancer patients.